These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 24766381)

  • 21. Preoperative bone health assessment and optimization in spine surgery.
    Anderson PA; Kadri A; Hare KJ; Binkley N
    Neurosurg Focus; 2020 Aug; 49(2):E2. PubMed ID: 32738805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for osteoporosis using easily obtainable biometrical data: diagnostic accuracy of measured, self-reported and recalled BMI, and related costs of bone mineral density measurements.
    van der Voort DJ; Brandon S; Dinant GJ; van Wersch JW
    Osteoporos Int; 2000; 11(3):233-9. PubMed ID: 10824239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of Screening for Osteoporosis in Older Men With a History of Falls.
    Ito K
    JAMA Netw Open; 2020 Dec; 3(12):e2027584. PubMed ID: 33258906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone densitometry and treatment for osteoporosis in older men.
    Ito K
    JAMA; 2007 Nov; 298(18):2136-7; author reply 2137. PubMed ID: 18000194
    [No Abstract]   [Full Text] [Related]  

  • 25. Osteoporosis Clinical Guideline. South African Medical Association--Osteoporosis Working Group.
    Hough S
    S Afr Med J; 2000 Sep; 90(9 Pt 2):907-44. PubMed ID: 11081144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoporotic fractures: background and prevention strategies.
    Wark JD
    Maturitas; 1996 Mar; 23(2):193-207. PubMed ID: 8735357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for osteoporosis.
    Croswell J
    Am Fam Physician; 2011 May; 83(10):1201-2. PubMed ID: 21568255
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost-effectiveness of bisphosphonates for prevention of fracture related to glucocorticoid-induced osteoporosis in Malaysia.
    Mohd-Tahir NA; Thomas P; Mohamed-Said MS; Makmor-Bakry M; Li SC
    Int J Rheum Dis; 2018 Mar; 21(3):647-655. PubMed ID: 29105349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinician's guide to prevention and treatment of osteoporosis.
    LeBoff MS; Greenspan SL; Insogna KL; Lewiecki EM; Saag KG; Singer AJ; Siris ES
    Osteoporos Int; 2022 Oct; 33(10):2049-2102. PubMed ID: 35478046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoporosis diagnosis and screening.
    Singer A
    Clin Cornerstone; 2006; 8(1):9-18. PubMed ID: 17591572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis.
    Blair MM; Carson DS; Barrington R
    J Fam Pract; 2000 Sep; 49(9):839-48. PubMed ID: 11032210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.
    Brown JP; Josse RG;
    CMAJ; 2002 Nov; 167(10 Suppl):S1-34. PubMed ID: 12427685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteoporosis in older men: recent advances in pathophysiology and treatment.
    Laurent M; Gielen E; Claessens F; Boonen S; Vanderschueren D
    Best Pract Res Clin Endocrinol Metab; 2013 Aug; 27(4):527-39. PubMed ID: 24054929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and Management of Osteoporosis.
    Jeremiah MP; Unwin BK; Greenawald MH; Casiano VE
    Am Fam Physician; 2015 Aug; 92(4):261-8. PubMed ID: 26280231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
    Yoshimura M; Moriwaki K; Noto S; Takiguchi T
    Osteoporos Int; 2017 Feb; 28(2):643-652. PubMed ID: 27743068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone density testing intervals and common sense.
    Lewiecki EM; Binkley N
    Curr Osteoporos Rep; 2012 Sep; 10(3):217-20. PubMed ID: 22723124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisphosphonates for the prevention and treatment of osteoporosis.
    Maraka S; Kennel KA
    BMJ; 2015 Sep; 351():h3783. PubMed ID: 26333528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for osteoporosis: U.S. preventive services task force recommendation statement.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2011 Mar; 154(5):356-64. PubMed ID: 21242341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of using clinical risk factors with and without DXA for osteoporosis screening in postmenopausal women.
    Mueller D; Gandjour A
    Value Health; 2009; 12(8):1106-17. PubMed ID: 19706151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence to inform decision makers in Thailand: a cost-effectiveness analysis of screening and treatment strategies for postmenopausal osteoporosis.
    Kingkaew P; Maleewong U; Ngarmukos C; Teerawattananon Y
    Value Health; 2012; 15(1 Suppl):S20-8. PubMed ID: 22265062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.